Study cites benefits of extended breast cancer therapy

12/11/2007 | Yahoo!

An Austrian study found a 38% decreased risk of local and regional breast cancer recurrence in postmenopausal patients who took an additional three-year anastrozole therapy after completing five years of successful tamoxifen therapy. However, researchers found no major distinction in terms of overall survival between the group taking either three years of anastrozole and those who did not undergo any further treatment.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC